查看购物车
  • Traditional Chinese
  • English
  • Japanese
2030 年全球真皮填充剂市场：按品牌（Juvederm、Sculptra、Radiesse）、产品（透明质酸、胶原蛋白、PLLA）、程序（皮肤再生、疤痕去除、脸部和身体塑形）和最终用户（皮肤科诊所、美容中心、医疗水疗中心）划分
市场调查报告书
商品编码
1773184

2030 年全球真皮填充剂市场：按品牌（Juvederm、Sculptra、Radiesse）、产品（透明质酸、胶原蛋白、PLLA）、程序（皮肤再生、疤痕去除、脸部和身体塑形）和最终用户（皮肤科诊所、美容中心、医疗水疗中心）划分

Derma Fillers Market by Brand (Juvederm, Sculptra, Radiesse), Product (Hyaluronic, Collagen, PLLA), Procedure (Skin Rejuvenation, Scar Removal, Face & Body Contouring), End User (Dermatology Clinic, Beauty Centers, Medical Spa) - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 223 Pages | 订单完成后即时交付

价格

预计真皮填充剂市场将经历显着成长，市场规模预计将从 2025 年的 41 亿美元增加到 2030 年的 73 亿美元。

研究范围
调查年份 2024-2030
基准年 2024
预测期 2024-2030
单元 金额（美元）
部分 按品牌、产品、程式、最终用户和地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

这一市场的成长受到多种因素的推动，其中包括对微创美容手术的需求。社群媒体趋势推动了填充剂的使用，尤其是在千禧世代和Z世代中，并使其不再被视为圭臬。同时，皱纹和皮肤体积减少等与老龄化相关的皮肤问题的普遍存在也推动了对美容手术的需求。

此外，填充剂在脸部、下巴和手部等新应用中的使用也不断增长，推动了个人化治疗的需求。

此外，持续的研发以及配方（例如生物分解性和长效注射剂）和注射技术的改进，确保了填充剂的长期安全性，使其成为对医生和患者更具吸引力的选择。预计这些趋势将在未来几年继续推动全球市场的成长。

“2024年天然真皮填充剂将占据市场主导地位”

天然真皮填充剂，尤其是基于透明质酸、胶原蛋白和其他生物分解性和生物相容性的材料的填充剂，由于其高度生物相容性、低过敏反应和副作用风险以及可逆性而引领市场。全球对微创美容手术日益增长的兴趣也推动了填充剂的成长，天然真皮填充剂被用作脸部回春、皱纹修復和丰盈的非手术替代方案。这种消费者主导的运动强调安全性、生物相容性和自然效果，尤其青睐透明质酸等生物分解性的填充剂。受千禧世代和 Z 世代的偏好以及社群媒体和青年文化的影响，这些天然真皮填充剂继续占据市场主导地位。

“预计亚太地区将在预测期内实现最高的复合年增长率”

这一增长是由人口结构、经济、文化和技术等多种因素共同推动的。人口结构变化是主要推动因素，例如年轻人和中年人对美容手术的认知和接受度不断提高，以及经济成长带来的中阶的扩大，这些变化导致可支配收入增加，使更多人能够接受非侵入性美容皮肤治疗。安全性、功效和持久性显着提高的新一代填充剂的研发和上市也在推动市场成长。此外，人们日益增长的美学意识、社交媒体的影响、持续的经济成长、人口老化、创新技术的不断引进、医疗旅游的发展、政府的支持性政策以及医疗基础设施的建设等各种因素都在加速市场的发展。因此，亚太地区真皮填充剂市场规模庞大、竞争激烈，由创新驱动，并持续快速成长。

本报告调查了全球真皮填充剂市场，并提供了市场概况、影响市场成长的各种因素分析、技术和专利趋势、法律制度、案例研究、市场规模趋势和预测、各个细分市场、地区/主要国家的详细分析、竞争格局和主要企业的概况。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章市场概述

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
  • 影响我们客户业务的趋势/中断
  • 定价分析
  • 价值链分析
  • 供应链分析
  • 生态系分析
  • 投资金筹措场景
  • 技术分析
  • 专利分析
  • 贸易分析
  • 2025-2026 年重要会议与活动
  • 案例研究分析
  • 监管状况
  • 波特五力分析
  • 主要相关人员和采购标准
  • 赎回方案
  • 未满足的需求和关键问题
  • 人工智慧将如何影响真皮填充剂市场
  • 美国关税

第六章 真皮填充剂市场（依品牌）

  • JUVEDERM
  • RESTYLANE
  • RHA COLLECTION
  • SCULPTRA
  • RADIESSE
  • LANLUMA
  • BELLAFILL
  • 其他的

7. 真皮填充剂市场（依产品类型）

  • 天然真皮填充剂
    • 透明质酸填充剂
    • 胶原蛋白填充剂
  • 合成填料
    • 烃基磷灰石钙（CAHA）填料
    • 聚左旋乳酸（PLLA）填料
    • 聚甲基丙烯酸甲酯（PMMA）填料
    • 多核苷酸填充剂
    • 其他合成填料

第八章 真皮填充剂市场（依治疗类型）

  • 皮肤再生
  • 脸部和身体塑形
  • 丰唇
  • 其他的

第九章 填料市场（依最终用户划分）

  • 皮肤科诊所和医院
  • 美容中心
  • 医疗水疗中心
  • 其他的

第 10 章 真皮填充剂市场（按地区）

  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 中东和非洲宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十一章竞争格局

  • 主要参与企业的策略/优势
  • 收益分析
  • 市场占有率分析
  • 估值和财务指标
  • 品牌/产品比较
  • 企业评估矩阵：主要企业
  • 公司估值矩阵：Start-Ups/小型企业
  • 竞争场景

第十二章 公司简介

  • 主要企业
    • ABBVIE INC.
    • GALDERMA
    • MERZ PHARMA
    • SILCLAIR PHARMA
    • REVANCE
    • CROMA PHARMA
    • EVOLUS, INC.
    • HUGEL, INC.
    • MEDYTOX
    • BIOXIS PHARMACEUTICAL
    • ZIMMER MEDIZINSYSTEME GMBH
    • CUTERA, INC.
    • SCIVISION BIOTECH INC.
    • BRIDGEPOINT GROUP PLC
    • ANIKA THERAPEUTICS, INC.
  • 其他公司
    • TIGER AESTHETICS MEDICAL
    • PROLLENIUM MEDICAL TECHNOLOGIES
    • BIOSCIENCE GMBH
    • DERMAX
    • TEOXANE
    • DR. KORMAN LABORATORIES LTD.
    • CYTOPHIL, INC.
    • TELETA PHARMA
    • IBSA DERMA
    • NEOGENESIS
    • CGBIO, CO., LTD.

第十三章 附录

Product Code: PH 9403

The derma fillers market is expected to experience significant growth, increasing from USD 4.1 billion in 2025 to USD 7.3 billion by 2030.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsBrand, Product, Procedure, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

This growth is fueled by various factors, including demand for minimally invasive aesthetic procedures. Social media trends have normalized and mythologized the use of dermal fillers, particularly among Millennials and Generation Z. Plus, the prevalence of age-related skin issues, such as wrinkles and loss of volume, is stimulating the need for aesthetic treatments.

Fillers are being used for added indications (e.g., jawline, chin, hands) and the demand for customized treatments.

Continuous R&D and improved formulations (e.g., biodegradable and long-lasting injectables) and injection techniques have assured the long-term safety of fillers, making them even more appealing to practitioners and patients. These trends will continue to spur the growth of the global market.

"Natural dermal fillers dominated the market in 2024."

Natural dermal fillers, particularly those based on hyaluronic acid (HA), collagen, and other biodegradable, biocompatible materials, lead the market because they are highly biocompatible and have little risk of allergic reactions or side effects, all while being reversible as well. The worldwide trend toward less invasive aesthetic procedures for aesthetic improvements is a significant contributor to growth, whereby natural dermal fillers provide a non-surgical alternative for facial rejuvenation, wrinkle correction, and volume restoration. Natural dermal fillers are generation and consumer-driven, sourcing from consumer demand for safety, biocompatibility, and a natural-looking result, as well as consumer trends toward minimally invasive procedures, customizable treatments, and the popularity of social media and youth culture. Hyaluronic acid and other biodegradable fillers dominate natural dermal fillers and highlight consumer priorities, as natural fillers remain the preferred choice in the fast-growing derma fillers market.

"The dermatology clinics & hospitals segment held the largest share of the derma fillers market in 2024."

Dermatology clinics & hospitals are the primary end user in the derma fillers market, they are being fueled by increasing aesthetic demand with rising consumer interest in facial aesthetics and youthful appearance, product innovation, an expanding treatment indicator where clinics and hospitals are expanding their offerings to facial contouring, volume restoration, lip augmentation, or even hand rejuvenation, based on new product approvals and continuous patient needs. Other influences contributing to the performance, expertise, professional alliances and collaborations, and the socioeconomic environment have allowed procedures to be realized by patients and professionals alike. These drivers collectively provide domain and procedural growth and a lot of uptake in dermal filler procedures in both the clinics and hospital settings.

"The Asia Pacific region is expected to register the highest CAGR in the derma fillers market during the forecast period."

The Asia Pacific (APAC) region is one of the fastest emerging markets for dermal fillers, with growth driven by an unparalleled combination of demographic, economic, cultural, and technological factors. Demographic changes especially rising awareness and acceptance of aesthetic procedures (in particular among the younger and middle-aged consumer base), economic growth - resulting in a larger middle class with greater spending capacity, which makes non-invasive cosmetic skin treatment options accessible to a much wider audience, R&D and product releases of next-generation fillers which have significantly improved safety, efficacy and longevity, are all contributing factors leading to the growth of the APAC dermal fillers market. The exploding beauty consciousness, social media, continuous economic growth, aging populations, sustained innovation, medical tourism, supportive government policies, and developing healthcare infrastructures represent some of the major accelerators to the APAC dermal fillers market. The APAC derma fillers market is a large and very competitive market undergoing constant and rapid growth, driven by innovation.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
  • By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
  • By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)

Prominent players in the derma fillers market include Allergan Aesthetics (US), Merz Pharma KGaA (Germany), Galderma (Switzerland), Sinclair Pharma (UK), Bioxis Pharmaceutical (France), Suneva Medical (US), Croma Pharma (Austria), Prollenium Medical Technologies (Canada), Dermax Med (China), Zimmer Aesthetics (Germany), Marllor Biomedical (Italy), MEDYTOX (South Korea), Revance Therapeutic (US), Dr. Korman Pharma (Israel), CGBio Co., Ltd. (South Korea), REGEN Biotech (UK), and BioScience GmbH (Germany), among others.

Research Coverage

  • The report studies the derma fillers market based on brand, product, procedure, end user, and region.
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
  • The report studies micro markets with respect to their growth trends, prospects, and contributions to the global derma fillers market.
  • The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying this Report

This report is valuable for both new and current players in the market, offering essential information to identify potential investment opportunities. It provides a comprehensive overview of both major and minor players, facilitating effective risk analysis and informed investment decisions. The report includes precise segmentation based on end users and geographical regions, offering detailed insights into niche market segments. Additionally, it highlights key trends, growth drivers, challenges, and opportunities, supporting strategic decision-making through a balanced analysis.

Through this report, readers get insightful views into the following parameters:

  • Analysis of key drivers (Increasing demand for non-invasive aesthetic treatments, continued R&D has grown the sophistication of products, i.e., biodegradable longer-lasting fillers, improved injecting techniques), restraints (Cost barriers to treatment and the need for repeated treatments due to temporary nature of most derma fillers, concerns about adverse effects or complications can also impede market growth), opportunities (Exploration of biodegradable and bioresorbable fillers, potential for fillers to be used in conjunction with other aesthetic treatments, such as the use of botulinum toxin and laser therapy), challenges (the possibility of complications, such as vascular occlusion, granulomas or allergic reactions, can damage patient trust in procedures and also reputation and therefore negatively impact the market), relating to the growth of the derma fillers market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product & service launches in the derma fillers market.
  • Market Development: Comprehensive information about lucrative markets - the report analyzes the derma fillers market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the derma fillers market
  • Competitive Assessment: A comprehensive analysis of market share, product offerings, and leading strategies of major players, such as Allergan Aesthetics (US), Merz Pharma KGaA (Germany), Galderma (Switzerland), Croma Pharma (Austria), Sinclair Pharma (UK), Bioxis Pharmaceutical (France), Suneva Medical (US), Prollenium Medical Technologies (Canada), Dermax Med (China), Zimmer Aesthetics (Germany), Marllor Biomedical (Italy), MEDYTOX (South Korea), Revance Therapeutic (US), Dr. Korman Pharma (Israel), CGBio Co., Ltd. (South Korea), REGEN Biotech (UK), and BioScience GmbH (Germany).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key secondary sources
      • 2.1.1.2 Key data from secondary sources
      • 2.1.1.3 Objectives of secondary research
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation
      • 2.2.1.2 Approach 2: Customer-based market estimation
      • 2.2.1.3 Approach 3: Primary interviews
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 GROWTH FORECAST
  • 2.4 DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 DERMA FILLERS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: DERMA FILLERS MARKET, BY PROCEDURE, 2025 VS. 2030 (USD MILLION)
  • 4.3 EUROPE: DERMA FILLERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • 4.4 DERMA FILLERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing adoption of minimally invasive and non-invasive aesthetic procedures
      • 5.2.1.2 Growing demand for aesthetic treatments among elderly and men
      • 5.2.1.3 Rising acceptance and normalization of fillers among millennials and Gen Z fueled by social media
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Risk of infection and safety concerns
      • 5.2.2.2 Complex regulatory framework and compliance standards
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging markets
      • 5.2.3.2 Launch of new technologies and products
    • 5.2.4 CHALLENGES
      • 5.2.4.1 High cost of treatments and devices
      • 5.2.4.2 Social and cultural barriers
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
    • 5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
    • 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.5 VALUE CHAIN ANALYSIS
    • 5.5.1 RESEARCH & DEVELOPMENT
    • 5.5.2 RAW MATERIAL PROCUREMENT AND PRODUCT MANUFACTURING
    • 5.5.3 DISTRIBUTION, MARKETING & SALES, AND AFTER-SALES SERVICES
  • 5.6 SUPPLY CHAIN ANALYSIS
    • 5.6.1 PROMINENT COMPANIES
    • 5.6.2 SMALL AND MEDIUM-SIZED ENTERPRISES
    • 5.6.3 END USERS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Advanced Hyaluronic Acid (HA) cross-linking
      • 5.9.1.2 Polymethylmethacrylate (PMMA) fillers
      • 5.9.1.3 Bio-stimulatory fillers
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Laser resurfacing
      • 5.9.2.2 Microneedling
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 3D imaging and AI-based facial mapping
  • 5.10 PATENT ANALYSIS
  • 5.11 TRADE ANALYSIS
    • 5.11.1 IMPORT SCENARIO (HS CODE 330499)
    • 5.11.2 EXPORT SCENARIO (HS CODE 330499)
  • 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.13 CASE STUDY ANALYSIS
    • 5.13.1 COMMERCIAL PARTNERSHIPS FOR AESTHETIC PRODUCT SALES
    • 5.13.2 DIVERSIFICATION OF BUSINESS TO MEET CUSTOMER DEMANDS
    • 5.13.3 COLLABORATIONS WITH SMES FOR STREAMLINING LASER-BASED DEVICES
  • 5.14 REGULATORY LANDSCAPE
    • 5.14.1 REGULATORY ANALYSIS
      • 5.14.1.1 North America
        • 5.14.1.1.1 US
        • 5.14.1.1.2 Canada
      • 5.14.1.2 Europe
        • 5.14.1.2.1 UK
        • 5.14.1.2.2 France
        • 5.14.1.2.3 Germany
      • 5.14.1.3 Asia Pacific
        • 5.14.1.3.1 Japan
        • 5.14.1.3.2 India
      • 5.14.1.4 Rest of the World
        • 5.14.1.4.1 Brazil
        • 5.14.1.4.2 UAE
    • 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.15 PORTER'S FIVE FORCES ANALYSIS
    • 5.15.1 BARGAINING POWER OF SUPPLIERS
    • 5.15.2 BARGAINING POWER OF BUYERS
    • 5.15.3 THREAT OF NEW ENTRANTS
    • 5.15.4 THREAT OF SUBSTITUTES
    • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.16.2 BUYING CRITERIA
  • 5.17 REIMBURSEMENT SCENARIO
  • 5.18 UNMET NEEDS AND KEY PAIN POINTS
  • 5.19 IMPACT OF AI ON DERMA FILLERS MARKET
    • 5.19.1 INTRODUCTION
    • 5.19.2 MARKET POTENTIAL OF AI ON DERMA FILLERS ECOSYSTEM
    • 5.19.3 AI USE CASES
    • 5.19.4 KEY COMPANIES IMPLEMENTING AI
    • 5.19.5 FUTURE OF GENERATIVE AI IN DERMA FILLERS MARKET
  • 5.20 US TARIFF 2025
    • 5.20.1 INTRODUCTION
    • 5.20.2 KEY TARIFF RATES
    • 5.20.3 PRICE IMPACT ANALYSIS
    • 5.20.4 IMPACT ON COUNTRY/REGION
      • 5.20.4.1 US
      • 5.20.4.2 Europe
      • 5.20.4.3 Asia Pacific
    • 5.20.5 IMPACT ON END-USE INDUSTRIES

6 DERMA FILLERS MARKET, BY BRAND

  • 6.1 INTRODUCTION
  • 6.2 JUVEDERM
    • 6.2.1 WIDE INDICATION COVERAGE AND GLOBAL REACH TO CONTRIBUTE TO GROWTH
  • 6.3 RESTYLANE
    • 6.3.1 FASTER ONSET DURATION AND LONG-LASTING EFFECT TO ENCOURAGE GROWTH
  • 6.4 RHA COLLECTION
    • 6.4.1 GROWING DESIRE FOR NATURAL EXPRESSIONS TO BOOST MARKET
  • 6.5 SCULPTRA
    • 6.5.1 INCREASED ADOPTION OF SCULPTRA AMONG ADVANCED INJECTORS TO BOLSTER GROWTH
  • 6.6 RADIESSE
    • 6.6.1 STABLE SUCCESS RATES AND DESIRED RESULTS TO SPUR GROWTH
  • 6.7 LANLUMA
    • 6.7.1 EXPANDED USE CASES IN BODY CONTOURING APPLICATIONS TO INTENSIFY GROWTH
  • 6.8 BELLAFILL
    • 6.8.1 USE OF BELLAFILL FOR TREATING DEEP ACNE SCARS AND NASOLABIAL FOLDS TO FOSTER GROWTH
  • 6.9 OTHER BRANDS

7 DERMA FILLERS MARKET, BY PRODUCT TYPE

  • 7.1 INTRODUCTION
  • 7.2 NATURAL DERMAL FILLERS
    • 7.2.1 HYALURONIC ACID FILLERS
      • 7.2.1.1 Wide clinical acceptance and safety profile to aid growth
    • 7.2.2 COLLAGEN FILLERS
      • 7.2.2.1 Ability to provide structural support and improved skin texture to boost market
  • 7.3 SYNTHETIC DERMAL FILLERS
    • 7.3.1 CALCIUM HYDROXYLAPATITE (CAHA) FILLERS
      • 7.3.1.1 Long-term collagen stimulation property to augment growth
    • 7.3.2 POLY-L-LACTIC ACID (PLLA) FILLERS
      • 7.3.2.1 Increasing desire for natural, progressive rejuvenation to stimulate growth
    • 7.3.3 POLYMETHYL METHACRYLATE (PMMA) FILLERS
      • 7.3.3.1 Long-lasting structural correction ability to favor growth
    • 7.3.4 POLYNUCLEOTIDE FILLERS
      • 7.3.4.1 Rising preference for skin revitalization procedures to fuel market
    • 7.3.5 OTHER SYNTHETIC FILLERS

8 DERMA FILLERS MARKET, BY PROCEDURE

  • 8.1 INTRODUCTION
  • 8.2 SKIN REJUVENATION
    • 8.2.1 INCREASING ACCEPTANCE AND REPEATABILITY OF SKIN PROCEDURES TO FACILITATE GROWTH
  • 8.3 FACE & BODY CONTOURING
    • 8.3.1 RISING NUMBER OF FACIAL AND BODY CONTOURING-RELATED PROCEDURES TO PROMOTE GROWTH
  • 8.4 LIP AUGMENTATION
    • 8.4.1 NEED FOR REPETITIVE CYCLES TO MAINTAIN DESIRED LOOK TO PROPEL MARKET
  • 8.5 OTHER PROCEDURES

9 DERMA FILLERS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 DERMATOLOGY CLINICS & HOSPITALS
    • 9.2.1 RISING TREND OF MEDICAL TOURISM AND PLASTIC SURGERY TO SUPPORT GROWTH
  • 9.3 BEAUTY CENTERS
    • 9.3.1 GROWING INCLINATION TOWARD CUSTOMIZED TREATMENT TO DRIVE MARKET
  • 9.4 MEDICAL SPAS
    • 9.4.1 INCREASING FOCUS ON CONVENIENCE, TREATMENT FLEXIBILITY, AND COST SAVING TO SPUR GROWTH
  • 9.5 OTHER END USERS

10 DERMA FILLERS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 Rising geriatric population to spur growth
    • 10.2.3 CANADA
      • 10.2.3.1 Preference of aging individuals to reduce aging signs to promote growth
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Large consumer base to expedite growth
    • 10.3.3 UK
      • 10.3.3.1 Increasing volume-enhancement treatments to support growth
    • 10.3.4 FRANCE
      • 10.3.4.1 Favorable demographics and increased acceptance of non-surgical procedures to aid growth
    • 10.3.5 ITALY
      • 10.3.5.1 Growing acceptance of minimally invasive procedures to fuel market
    • 10.3.6 SPAIN
      • 10.3.6.1 Increasing availability of safe and minimally invasive treatments to augment growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 JAPAN
      • 10.4.2.1 Growing trend of volume restoration and wrinkle correction to boost market
    • 10.4.3 CHINA
      • 10.4.3.1 Surging demand for aesthetic procedures to accelerate growth
    • 10.4.4 INDIA
      • 10.4.4.1 Rapid urbanization and proliferation of clinics to stimulate growth
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Rising safety standards for non-surgical cosmetic procedures to encourage growth
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Robust medical infrastructure to speed up growth
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Cultural normalization of aesthetic treatments to contribute to growth
    • 10.5.3 MEXICO
      • 10.5.3.1 Increasing inflow of medical tourists to sustain growth
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Booming aesthetic tourism sector to facilitate growth
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.3 REVENUE ANALYSIS, 2020-2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
    • 11.4.1 NATURAL DERMA FILLERS MARKET SHARE
    • 11.4.2 SYNTHETIC DERMAL FILLERS MARKET SHARE
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.6 BRAND/PRODUCT COMPARISON
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.7.5.1 Company footprint
      • 11.7.5.2 Region footprint
      • 11.7.5.3 Product type footprint
      • 11.7.5.4 Procedure footprint
      • 11.7.5.5 End-user footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • 11.8.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
      • 11.8.5.1 Detailed list of key startups/SMEs
      • 11.8.5.2 Competitive benchmarking of key startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 11.9.2 DEALS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 ABBVIE INC.
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches and approvals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 GALDERMA
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product launches and approvals
        • 12.1.2.3.2 Deals
        • 12.1.2.3.3 Expansions
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses and competitive threats
    • 12.1.3 MERZ PHARMA
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Expansions
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 SILCLAIR PHARMA
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 MnM view
        • 12.1.4.3.1 Key strengths
        • 12.1.4.3.2 Strategic choices
        • 12.1.4.3.3 Weaknesses and competitive threats
    • 12.1.5 REVANCE
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches and approvals
        • 12.1.5.3.2 Deals
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses and competitive threats
    • 12.1.6 CROMA PHARMA
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
    • 12.1.7 EVOLUS, INC.
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Product launches and approvals
    • 12.1.8 HUGEL, INC.
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
    • 12.1.9 MEDYTOX
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
    • 12.1.10 BIOXIS PHARMACEUTICAL
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
    • 12.1.11 ZIMMER MEDIZINSYSTEME GMBH
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
    • 12.1.12 CUTERA, INC.
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Product launches and approvals
        • 12.1.12.3.2 Deals
    • 12.1.13 SCIVISION BIOTECH INC.
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
    • 12.1.14 BRIDGEPOINT GROUP PLC
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
    • 12.1.15 ANIKA THERAPEUTICS, INC.
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 TIGER AESTHETICS MEDICAL
    • 12.2.2 PROLLENIUM MEDICAL TECHNOLOGIES
    • 12.2.3 BIOSCIENCE GMBH
    • 12.2.4 DERMAX
    • 12.2.5 TEOXANE
    • 12.2.6 DR. KORMAN LABORATORIES LTD.
    • 12.2.7 CYTOPHIL, INC.
    • 12.2.8 TELETA PHARMA
    • 12.2.9 IBSA DERMA
    • 12.2.10 NEOGENESIS
    • 12.2.11 CGBIO, CO., LTD.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 DERMA FILLERS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2021-2023
  • TABLE 3 DERMA FILLERS MARKET: RISK ANALYSIS
  • TABLE 4 AVERAGE SELLING PRICE TREND OF HYALURONIC ACID FILLERS, BY KEY PLAYER, 2022-2024 (USD)
  • TABLE 5 AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS, BY REGION, 2022-2024 (USD)
  • TABLE 6 DERMA FILLERS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 7 DERMA FILLERS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
  • TABLE 8 IMPORT DATA FOR HS CODE 330499, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 9 EXPORT DATA FOR HS CODE 611510, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 10 DERMA FILLERS MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 DERMA FILLERS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 18 KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING DERMA FILLERS
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DERMA FILLERS, BY PRODUCT TYPE (%)
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • TABLE 21 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
  • TABLE 22 UNMET CUSTOMER NEEDS AND KEY PAIN POINTS
  • TABLE 23 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 24 DERMA FILLERS MARKET, BY BRAND, 2023-2030 (USD MILLION)
  • TABLE 25 DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 26 NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 27 NORTH AMERICA: NATURAL DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 28 EUROPE: NATURAL DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 ASIA PACIFIC: NATURAL DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 LATIN AMERICA: NATURAL DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 MIDDLE EAST & AFRICA: NATURAL DERMAL FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 32 NATURAL DERMAL FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 33 NATURAL DERMAL FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 34 HYALURONIC ACID FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 COLLAGEN FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 36 SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 37 NORTH AMERICA: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 EUROPE: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 LATIN AMERICA: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 MIDDLE EAST & AFRICA: SYNTHETIC DERMAL FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 42 SYNTHETIC DERMAL FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 43 SYNTHETIC DERMAL FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 44 CALCIUM HYDROXYLAPATITE (CAHA) FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 45 POLY-L-LACTIC ACID (PLLA) FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 POLYMETHYL METHACRYLATE (PMMA) FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 47 POLYNUCLEOTIDE FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 48 OTHER SYNTHETIC FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 49 DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 50 DERMA FILLERS MARKET FOR SKIN REJUVENATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 51 DERMA FILLERS MARKET FOR FACE & BODY CONTOURING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 DERMA FILLERS MARKET FOR LIP AUGMENTATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 53 DERMA FILLERS MARKET FOR OTHER PROCEDURES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 54 DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 55 DERMA FILLERS MARKET FOR DERMATOLOGY CLINICS & HOSPITALS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 56 DERMA FILLERS MARKET FOR BEAUTY CENTERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 57 DERMA FILLERS MARKET FOR MEDICAL SPAS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 DERMA FILLERS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 59 DERMA FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 60 GLOBAL DERMA FILLERS PROCEDURE, 2021-2023
  • TABLE 61 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 62 NORTH AMERICA: DERMA FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 68 US: DERMA FILLER PROCEDURES, 2021-2023
  • TABLE 69 US: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 70 CANADA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 71 EUROPE: DERMA FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 72 EUROPE: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 73 EUROPE: NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 74 EUROPE: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 75 EUROPE: DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 76 EUROPE: DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 77 EUROPE: MACROECONOMIC OUTLOOK
  • TABLE 78 GERMANY: DERMA FILLER PROCEDURES, 2021-2023
  • TABLE 79 GERMANY: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 80 UK: DERMA FILLER PROCEDURES, 2022-2023
  • TABLE 81 UK: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 FRANCE: DERMA FILLER PROCEDURES, 2023
  • TABLE 83 FRANCE: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 84 ITALY: DERMA FILLER PROCEDURES, 2021-2023
  • TABLE 85 ITALY: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 86 SPAIN: DERMA FILLER PROCEDURES, 2021-2023
  • TABLE 87 SPAIN: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 88 REST OF EUROPE: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 89 ASIA PACIFIC: MACROECONOMIC OUTLOOK
  • TABLE 90 ASIA PACIFIC: DERMA FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 ASIA PACIFIC: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 93 ASIA PACIFIC: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 96 JAPAN: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 97 CHINA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 98 INDIA: DERMA FILLER PROCEDURES, 2021-2023
  • TABLE 99 INDIA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 100 AUSTRALIA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 101 SOUTH KOREA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 102 REST OF ASIA PACIFIC: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 103 LATIN AMERICA: DERMA FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 104 LATIN AMERICA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 LATIN AMERICA: NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 106 LATIN AMERICA: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 107 LATIN AMERICA: DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 108 LATIN AMERICA: DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 109 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 110 BRAZIL: DERMA FILLER PROCEDURES, 2021-2023
  • TABLE 111 BRAZIL: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 MEXICO: DERMA FILLER PROCEDURES, 2021-2023
  • TABLE 113 MEXICO: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 REST OF LATIN AMERICA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • TABLE 116 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 117 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 118 MIDDLE EAST & AFRICA: NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 119 MIDDLE EAST & AFRICA: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 120 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
  • TABLE 121 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 122 GCC COUNTRIES: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 REST OF MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 124 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN DERMA FILLERS MARKET, JANUARY 2022-MAY 2025
  • TABLE 125 DERMA FILLERS MARKET: DEGREE OF COMPETITION
  • TABLE 126 DERMA FILLERS MARKET: REGION FOOTPRINT
  • TABLE 127 DERMA FILLERS MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 128 DERMA FILLERS MARKET: PROCEDURE FOOTPRINT
  • TABLE 129 DERMA FILLERS MARKET: END-USER FOOTPRINT
  • TABLE 130 DERMA FILLERS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 131 DERMA FILLERS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 132 DERMA FILLERS MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
  • TABLE 133 DERMA FILLERS MARKET: DEALS, JANUARY 2021-MAY 2025
  • TABLE 134 ABBVIE INC.: COMPANY OVERVIEW
  • TABLE 135 ABBVIE INC.: PRODUCTS OFFERED
  • TABLE 136 ABBVIE INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
  • TABLE 137 GALDERMA: COMPANY OVERVIEW
  • TABLE 138 GALDERMA: PRODUCTS OFFERED
  • TABLE 139 GALDERMA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
  • TABLE 140 GALDERMA: DEALS, JANUARY 2021-MAY 2025
  • TABLE 141 GALDERMA: EXPANSIONS, JANUARY 2021-MAY 2025
  • TABLE 142 MERZ PHARMA: COMPANY OVERVIEW
  • TABLE 143 MERZ PHARMA: PRODUCTS OFFERED
  • TABLE 144 MERZ PHARMA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
  • TABLE 145 MERZ PHARMA: EXPANSIONS, JANUARY 2021-MAY 2024
  • TABLE 146 SILCLAIR PHARMA: COMPANY OVERVIEW
  • TABLE 147 SILCLAIR PHARMA: PRODUCTS OFFERED
  • TABLE 148 REVANCE: COMPANY OVERVIEW
  • TABLE 149 REVANCE: PRODUCTS OFFERED
  • TABLE 150 REVANCE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
  • TABLE 151 REVANCE: DEALS, JANUARY 2021-MAY 2025
  • TABLE 152 CROMA PHARMA: COMPANY OVERVIEW
  • TABLE 153 CROMA PHARMA: PRODUCTS OFFERED
  • TABLE 154 EVOLUS, INC.: COMPANY OVERVIEW
  • TABLE 155 EVOLUS, INC.: PRODUCTS OFFERED
  • TABLE 156 EVOLUS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
  • TABLE 157 HUGEL, INC.: COMPANY OVERVIEW
  • TABLE 158 HUGEL, INC.: PRODUCTS OFFERED
  • TABLE 159 MEDYTOX: COMPANY OVERVIEW
  • TABLE 160 MEDYTOX: PRODUCTS OFFERED
  • TABLE 161 BIOXIS PHARMACEUTICAL: COMPANY OVERVIEW
  • TABLE 162 BIOXIS PHARMACEUTICAL: PRODUCTS OFFERED
  • TABLE 163 ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW
  • TABLE 164 ZIMMER MEDIZINSYSTEME GMBH: PRODUCTS OFFERED
  • TABLE 165 CUTERA, INC.: COMPANY OVERVIEW
  • TABLE 166 CUTERA, INC.: PRODUCTS OFFERED
  • TABLE 167 CUTERA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
  • TABLE 168 CUTERA, INC.: DEALS, JANUARY 2021-MAY 2025
  • TABLE 169 SCIVISION BIOTECH INC.: COMPANY OVERVIEW
  • TABLE 170 SCIVISION BIOTECH INC.: PRODUCTS OFFERED
  • TABLE 171 BRIDGEPOINT GROUP PLC: COMPANY OVERVIEW
  • TABLE 172 BRIDGEPOINT GROUP PLC: PRODUCTS OFFERED
  • TABLE 173 ANIKA THERAPEUTICS, INC.: COMPANY OVERVIEW
  • TABLE 174 ANIKA THERAPEUTICS, INC.: PRODUCTS OFFERED
  • TABLE 175 TIGER AESTHETICS MEDICAL: COMPANY OVERVIEW
  • TABLE 176 PROLLENIUM MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 177 BIOSCIENCE GMBH: COMPANY OVERVIEW
  • TABLE 178 DERMAX: COMPANY OVERVIEW
  • TABLE 179 TEOXANE: COMPANY OVERVIEW
  • TABLE 180 DR. KORMAN LABORATORIES LTD.: COMPANY OVERVIEW
  • TABLE 181 CYTOPHIL, INC.: COMPANY OVERVIEW
  • TABLE 182 TELETA PHARMA: COMPANY OVERVIEW
  • TABLE 183 IBSA DERMA: COMPANY OVERVIEW
  • TABLE 184 NEOGENESIS: COMPANY OVERVIEW
  • TABLE 185 CGBIO, CO., LTD.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 DERMA FILLERS MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 DERMA FILLERS MARKET: RESEARCH DESIGN
  • FIGURE 3 DERMA FILLERS MARKET: RESEARCH DATA
  • FIGURE 4 KEY PRIMARY SOURCES
  • FIGURE 5 SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 8 MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
  • FIGURE 9 DERMA FILLERS MARKET SIZE ESTIMATION METHODOLOGY
  • FIGURE 10 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 11 GROWTH RATE PROJECTIONS BASED ON MARKET DRIVERS
  • FIGURE 12 GROWTH RATE PROJECTIONS BASED ON MARKET OPPORTUNITIES, RESTRAINTS, AND CHALLENGES
  • FIGURE 13 DATA TRIANGULATION
  • FIGURE 14 DERMA FILLERS MARKET, BY BRAND, 2025 VS. 2030
  • FIGURE 15 DERMA FILLERS MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 DERMA FILLERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 DERMA FILLERS MARKET: GEOGRAPHIC SNAPSHOT (2024)
  • FIGURE 18 INCREASED AESTHETIC CONSCIOUSNESS AND RISING DISPOSABLE INCOME TO DRIVE MARKET
  • FIGURE 19 SKIN REJUVENATION SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 20 DERMATOLOGY CLINICS & HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 21 CHINA TO REGISTER HIGHEST CAGR FROM 2025 TO 2030
  • FIGURE 22 DERMA FILLERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 NEW REVENUE POCKETS FOR PLAYERS IN DERMA FILLERS MARKET
  • FIGURE 24 AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS, BY TYPE, 2022-2024 (USD)
  • FIGURE 25 AVERAGE SELLING PRICE TREND OF HYALURONIC ACID FILLERS, BY KEY PLAYER, 2022-2024 (USD)
  • FIGURE 26 AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS, BY REGION, 2022-2024 (USD)
  • FIGURE 27 DERMA FILLERS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 28 DERMA FILLERS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 DERMA FILLERS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 30 INVESTMENT AND FUNDING SCENARIO, 2019-2023 (USD MILLION)
  • FIGURE 31 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
  • FIGURE 32 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 33 DERMA FILLERS MARKET: PATENT ANALYSIS, 2014-2024
  • FIGURE 34 DERMA FILLERS MARKET: IMPORT SCENARIO FOR HS CODE 330499, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • FIGURE 35 DERMA FILLERS MARKET: EXPORT SCENARIO FOR HS CODE 330499, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • FIGURE 36 DERMA FILLERS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DERMA FILLERS, BY PRODUCT TYPE
  • FIGURE 38 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 39 NORTH AMERICA: DERMA FILLERS MARKET SNAPSHOT
  • FIGURE 40 ASIA PACIFIC: DERMA FILLERS MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN DERMA FILLERS MARKET, 2020-2024
  • FIGURE 42 NATURAL DERMAL FILLERS MARKET SHARE ANALYSIS, 2024
  • FIGURE 43 SYNTHETIC DERMA FILLERS MARKET SHARE ANALYSIS, 2024
  • FIGURE 44 EV/EBITDA OF KEY VENDORS
  • FIGURE 45 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 46 DERMA FILLERS MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 47 DERMA FILLERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 48 DERMA FILLERS MARKET: COMPANY FOOTPRINT
  • FIGURE 49 DERMA FILLERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 50 ABBVIE INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 51 GALDERMA: COMPANY SNAPSHOT (2024)
  • FIGURE 52 EVOLUS, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 53 HUGEL, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 54 MEDYTOX: COMPANY SNAPSHOT (2024)
  • FIGURE 55 SCIVISION BIOTECH INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 56 ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2024)